{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:03:19Z","timestamp":1782320599148,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.toxlet.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T11:03:48Z","timestamp":1476529428000},"page":"173-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Optical isomers of dihydropyridine calcium channel blockers display enantiospecific effects on the expression and enzyme activities of human xenobiotics-metabolizing cytochromes P450"],"prefix":"10.1016","volume":"262","author":[{"given":"Martina","family":"\u0160t\u011bp\u00e1nkov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krist\u00fdna","family":"Krasulov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Do\u0159i\u010d\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Kurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Anzenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"Dvo\u0159\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.toxlet.2016.10.005_bib0005","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.toxlet.2016.10.005_bib0010","series-title":"Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis","author":"Copeland","year":"2000"},{"issue":"33","key":"10.1016\/j.toxlet.2016.10.005_bib0015","doi-asserted-by":"crossref","first-page":"17221","DOI":"10.1016\/S0021-9258(19)77819-3","article-title":"The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis","volume":"263","author":"Denison","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.toxlet.2016.10.005_bib0020","first-page":"1325","article-title":"Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes","volume":"29","author":"Drocourt","year":"2001","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.toxlet.2016.10.005_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/chir.530020408","article-title":"Stereoselective inhibition of thromboxane-induced Coronary vasoconstriction by 1,4-dihydropyridine calcium-channel antagonists","volume":"2","author":"Eltze","year":"1990","journal-title":"Chirality"},{"issue":"1\u20132","key":"10.1016\/j.toxlet.2016.10.005_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0009-2797(97)00072-0","article-title":"Long-term primary cultures of adult human hepatocytes","volume":"107","author":"Ferrini","year":"1997","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.toxlet.2016.10.005_bib0035","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/jm00110a012","article-title":"Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4","volume":"34","author":"Guengerich","year":"1991","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.toxlet.2016.10.005_bib0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbapap.2010.07.017","article-title":"Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations","volume":"1814","author":"Hendrychova","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxlet.2016.10.005_bib0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.37.1.361","article-title":"Molecular determinants of drug binding and action on L-type calcium channels","volume":"37","author":"Hockerman","year":"1997","journal-title":"Annu. Rev. Pharmacol."},{"issue":"10","key":"10.1016\/j.toxlet.2016.10.005_bib0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0090-9556(25)08415-6","article-title":"The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism","volume":"24","author":"Holtbecker","year":"1996","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.toxlet.2016.10.005_bib0055","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0009-9236(97)90191-0","article-title":"Itraconazole greatly increases plasma concentrations and effects of felodipine","volume":"61","author":"Jalava","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.toxlet.2016.10.005_bib0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jchromb.2004.10.006","article-title":"Analysis of benidipine enantiomers in human plasma by liquid chromatography-mass spectrometry using a macrocyclic antibiotic (Vancomycin) chiral stationary phase column","volume":"814","author":"Kang","year":"2005","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"11\u201312","key":"10.1016\/j.toxlet.2016.10.005_bib0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s002280050706","article-title":"Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug\u2013drug interactions","volume":"55","author":"Katoh","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.toxlet.2016.10.005_bib0070","doi-asserted-by":"crossref","first-page":"e0137720","DOI":"10.1371\/journal.pone.0137720","article-title":"Optical isomers of atorvastatin, rosuvastatin and fluvastatin enantiospecifically activate pregnane x receptor PXR and induce CYP2A6, CYP2B6 and CYP3A4 in human hepatocytes","volume":"10","author":"Korhonova","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.toxlet.2016.10.005_bib0075","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1172\/JCI119439","article-title":"Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression","volume":"99","author":"Lown","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.toxlet.2016.10.005_bib0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0090-9556(24)15118-5","article-title":"Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A","volume":"28","author":"Ma","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"11A","key":"10.1016\/j.toxlet.2016.10.005_bib0085","first-page":"1662","article-title":"Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethyl-4-(3-Nitrophenyl)-3 nakamizo, 5-Pyridinedicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester","volume":"38-2","author":"Muto","year":"1988","journal-title":"Arzneimittel-Forsch."},{"issue":"8","key":"10.1016\/j.toxlet.2016.10.005_bib0090","doi-asserted-by":"crossref","first-page":"e105580","DOI":"10.1371\/journal.pone.0105580","article-title":"Omeprazole and lansoprazole enantiomers induce CYP3A4 in human hepatocytes and cell lines via glucocorticoid receptor and pregnane X receptor axis","volume":"9","author":"Novotna","year":"2014","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.toxlet.2016.10.005_bib0095","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1021\/es2029334","article-title":"Novel stably transfected gene reporter human hepatoma cell line for assessment of aryl hydrocarbon receptor transcriptional activity: construction and characterization","volume":"45","author":"Novotna","year":"2011","journal-title":"Environ. Sci. Technol."},{"issue":"5","key":"10.1016\/j.toxlet.2016.10.005_bib0100","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ejps.2012.10.003","article-title":"Construction and characterization of a reporter gene cell line for assessment of human glucocorticoid receptor activation","volume":"47","author":"Novotna","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.toxlet.2016.10.005_bib0105","doi-asserted-by":"crossref","first-page":"e101832","DOI":"10.1371\/journal.pone.0101832","article-title":"Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor","volume":"9","author":"Novotna","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.toxlet.2016.10.005_bib0110","doi-asserted-by":"crossref","first-page":"e111286","DOI":"10.1371\/journal.pone.0111286","article-title":"Dual effects of ketoconazole cis-enantiomers on CYP3A4 in human hepatocytes and HepG2Cells","volume":"9","author":"Novotna","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.toxlet.2016.10.005_bib0115","doi-asserted-by":"crossref","first-page":"e98711","DOI":"10.1371\/journal.pone.0098711","article-title":"Differential effects of omeprazole and lansoprazole enantiomers on aryl hydrocarbon receptor in human hepatocytes and cell lines","volume":"9","author":"Novotna","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.toxlet.2016.10.005_bib0120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bcp.2009.08.017","article-title":"Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene","volume":"79","author":"Pavek","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2016.10.005_bib0125","series-title":"Cytochrome P450 Protocols","author":"Phillips","year":"2006"},{"key":"10.1016\/j.toxlet.2016.10.005_bib0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00003495-199000402-00004","article-title":"Pharmacology of the calcium-antagonist isradipine","volume":"40","author":"Ruegg","year":"1990","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.toxlet.2016.10.005_bib0135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1248\/bpb.19.430","article-title":"Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients","volume":"19","author":"Shimada","year":"1996","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.toxlet.2016.10.005_bib0140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfp097","article-title":"Chiral toxicology: it's the same ThingOnly different","volume":"110","author":"Smith","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.toxlet.2016.10.005_bib0145","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00228-014-1716-8","article-title":"Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug\u2013drug interactions","volume":"70","author":"Snyder","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.toxlet.2016.10.005_bib0150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jbt.21516","article-title":"Effects of oral anorexiant sibutramine on the expression of cytochromes P450 s in human hepatocytes and cancer cell lines","volume":"27","author":"Vrzal","year":"2013","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.toxlet.2016.10.005_bib0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0773.1999.tb00085.x","article-title":"Midazolam alpha-hydroxylation by human liver microsomes in vitro: inhibition by calcium channel blockers, itraconazole and ketoconazole","volume":"85","author":"Wang","year":"1999","journal-title":"Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.toxlet.2016.10.005_bib0160","doi-asserted-by":"crossref","first-page":"e2487","DOI":"10.1097\/MD.0000000000002487","article-title":"Risks of adverse events following coprescription of statins and calcium channel blockers: a nationwide population-based study","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.toxlet.2016.10.005_bib0165","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1124\/dmd.106.013607","article-title":"Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes","volume":"35","author":"Yoon","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.toxlet.2016.10.005_bib0170","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/dmd.105.006569","article-title":"Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152\/81","volume":"34","author":"Zhang","year":"2006","journal-title":"Drug Metab. Dispos."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427416332696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427416332696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T13:36:34Z","timestamp":1749648994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427416332696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":34,"alternative-id":["S0378427416332696"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.10.005","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optical isomers of dihydropyridine calcium channel blockers display enantiospecific effects on the expression and enzyme activities of human xenobiotics-metabolizing cytochromes P450","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}